Cost-Effectiveness Analysis of Rivaroxaban in Chinese Patients With Stable Cardiovascular Disease

Cost-Effectiveness Analysis of Rivaroxaban in Chinese Patients With Stable Cardiovascular Disease

Objective: This study aimed to investigate the cost-effectiveness of low-dose rivaroxaban plus aspirin versus aspirin alone for patients with stable cardiovascular diseases in the China.Methods: We used TreeAge 2019 to construct a Markov model to assess the direct healthcare costs and quality-adjust...

Full description

Bibliographic Details
Main Authors: Tianyu Feng, Zhou Zheng, Shang Gao, Jiaying Xu, Pen Cao, Huanhuan Jia, Xihe Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pharmacology
Subjects:
rivaroxaban
aspirin
cost-effectiveness
COMPASS
markov model
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.921387/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.921387/full

Similar Items